首页> 外文期刊>The Journal of Steroid Biochemistry and Molecular Biology >Identification of covalent attachment site of antiestrogenic estradiol 11 beta-derivatives on human estrogen receptor alpha ligand-binding domain.
【24h】

Identification of covalent attachment site of antiestrogenic estradiol 11 beta-derivatives on human estrogen receptor alpha ligand-binding domain.

机译:鉴定抗雌激素雌二醇11β衍生物在人雌激素受体α配体结合域上的共价连接位点。

获取原文
获取原文并翻译 | 示例
           

摘要

Affinity labeling of human estrogen receptor alpha (ERalpha) by high affinity and antiestrogenic estradiol (E(2)) 11 beta-derivatives, 11 beta-bromoacetamidoethoxyphenylE(2) (11BAEOPE(2)) and 11 beta-bromoacetamidopentoxyphenylE(2) (11BAPOPE(2)) was studied using glutathione-S-transferase (GST) fused to the ligand-binding domain (LBD) of human ERalpha. To identify and quantify the electrophile covalent attachment sites on LBD, [(14)C]11BAEOPE(2)- and [(14)C]11BAPOPE(2)-alkylated LBD were separated from GST, purified, and then trypsinized. HPLC of LBD tryptic fragments afforded one and two radioactive peaks (the ratio of the two latter peaks was 84/16) in the chromatograms related to LBD alkylated by 11BAEOPE(2) and 11BAPOPE(2), respectively. Mass spectrometry (MS) analyses of the fractions related to the single peak and to the major one of the two peaks showed signals which accurately matched the mass of electrophile-alkylated Cys(530)Lys(531) LBD tryptic peptide, whereas no signal compatible with an alkylated form of an LBD tryptic peptide was detected in the MS analysis of the minor peak-related fractions. MS/MS analysis of alkylated CysLys dipeptide revealed the presence of fragments that unambiguously designated the Cys S as the covalent attachment site of the electrophiles. We attempted to interpret the biochemical data by molecular modeling using various crystallographic structures of human LBD-ligand complexes. In agreement with the endocrine properties of electrophiles, labeling at Cys(530) could be accounted for by a LBD structure derived from LBD bound to 4-hydroxytamoxifen, a triphenylethylene antiestrogen. The common attachment to Cys(530) of estrogenic E(2) 17 alpha-derivatives [H. Mattras, S. Aliau, E. Demey, J. Poncet, J.L. Borgna, Mass spectrometry identification of covalent attachment sites of two related estrogenic ligands on human estrogen receptor alpha, J. Steroid Biochem. Mol. Biol. 98 (4-5), in press] and antiestrogenic E(2) 11 beta-derivatives suggests that the LBD portion encompassing this amino acid possesses a marked plasticity.
机译:高亲和力和抗雌激素(E(2))11β-衍生物,11β-溴乙酰氨基乙氧基苯基E(2)(11BAEOPE(2))和11β-溴乙酰乙酰氨基戊氧基苯基E(2)(11BAPOPE)对人类雌激素受体α(ERalpha)的亲和标记(2))使用与人ERalpha配体结合域(LBD)融合的谷胱甘肽S-转移酶(GST)进行了研究。为了鉴定和量化LBD上的亲电子共价连接位点,将[(14)C] 11BAEOPE(2)-和[(14)C] 11BAPOPE(2)-烷基化的LBD与GST分离,纯化,然后进行胰蛋白酶处理。 LBD胰蛋白酶片段的HPLC在与11BAEOPE(2)和11BAPOPE(2)烷基化的LBD有关的色谱图中分别提供了一个和两个放射性峰(后两个峰的比率为84/16)。质谱(MS)对与单个峰和两个峰中的一个主要峰相关的馏分的分析显示,信号与亲电烷基化的Cys(530)Lys(531)LBD胰蛋白酶肽的质量精确匹配,但没有信号兼容质谱分析了次要峰相关馏分,检测到具有烷基化形式的LBD胰蛋白酶肽的SNP。烷基化的CysLys二肽的MS / MS分析显示,明确存在将Cys S指定为亲电子试剂的共价连接位点的片段。我们试图通过使用人类LBD-配体复合物的各种晶体结构的分子建模来解释生化数据。与亲电试剂的内分泌特性一致,在Cys(530)处的标记可能是由LBD结构衍生而来的,该LBD结构是由与四羟基他莫昔芬(一种三苯乙烯抗雌激素)结合的LBD衍生的。雌激素E(2)17 alpha衍生物对Cys(530)的常见附着[H. Mattras,S.Aliau,E.Demey,J.Poncet,J.L.Borgna,质谱法鉴定人雌激素受体α上两个相关雌激素配体的共价结合位点,J.Steroid Biochem。大声笑生物学98(4-5),正在印刷中]和抗雌激素E(2)11β衍生物表明,包含该氨基酸的LBD部分具有明显的可塑性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号